Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;24(3):490-7.
doi: 10.1158/1055-9965.EPI-14-0853. Epub 2014 Dec 23.

Intraindividual variation and short-term temporal trend in DNA methylation of human blood

Affiliations

Intraindividual variation and short-term temporal trend in DNA methylation of human blood

Yurii B Shvetsov et al. Cancer Epidemiol Biomarkers Prev. 2015 Mar.

Abstract

Background: Between- and within-person variation in DNA methylation levels are important parameters to be considered in epigenome-wide association studies. Temporal change is one source of within-person variation in DNA methylation that has been linked to aging and disease.

Methods: We analyzed CpG-site-specific intraindividual variation and short-term temporal trend in leukocyte DNA methylation among 24 healthy Chinese women, with blood samples drawn at study entry and after 9 months. Illumina HumanMethylation450 BeadChip was used to measure methylation. Intraclass correlation coefficients (ICC) and trend estimates were summarized by genomic location and probe type.

Results: The median ICC was 0.36 across nonsex chromosomes and 0.80 on the X chromosome. There was little difference in ICC profiles by genomic region and probe type. Among CpG loci with high variability between participants, more than 99% had ICC > 0.8. Statistically significant trend was observed in 10.9% CpG loci before adjustment for cell-type composition and in 3.4% loci after adjustment.

Conclusions: For CpG loci differentially methylated across subjects, methylation levels can be reliably assessed with one blood sample. More samples per subject are needed for low-variability and unmethylated loci. Temporal changes are largely driven by changes in cell-type composition of blood samples, but temporal trend unrelated to cell types is detected in a small percentage of CpG sites.

Impact: This study shows that one measurement can reliably assess methylation of differentially methylated CpG loci. Cancer Epidemiol Biomarkers Prev; 24(3); 490-7. ©2014 AACR.

PubMed Disclaimer

Conflict of interest statement

POTENTIAL CONFLICTS OF INTEREST: None reported

Figures

Figure 1
Figure 1
Scatter plot of within- vs. between-person standard error (β-scale), all CpG sites.
Figure 2
Figure 2
The effect of quantile normalization on ICC distribution and trend estimates, all CpG sites. (A) High, mid and low ICC distribution for untransformed and quantile-normalized methylation levels, by genomic location and probe type. (B) Proportion of CpG loci with significant temporal trend for untransformed and quantile-normalized methylation levels, by genomic location and probe type. All estimates are adjusted for cell type composition. DMR: differentially methylated region; TSS: transcription start site; UTR: untranslated region.
Figure 3
Figure 3
The effect of cell-type composition adjustment and quantile normalization on temporal trend in DNA methylation: scatter plots of trend estimates. (A) Untransformed vs. quantile-normalized data, no cell-type adjustment. (B) Untransformed data: without vs. with cell-type adjustment. (C) Untransformed vs. quantile-normalized data, with cell-type adjustment., (D) Untransformed data with cell-type adjustment vs. quantile-normalized data without cell-type adjustment. All plots show only CpG loci with significant trend in both models. CTA: cell type adjustment; QN: quantile normalization.

References

    1. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One. 2009;4:e8274. - PMC - PubMed
    1. Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol. 2011;29:1133–9. - PMC - PubMed
    1. Yang R, Pfutze K, Zucknick M, Sutter C, Wappenschmidt B, Marme F, et al. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood. Int J Cancer. 2014 - PubMed
    1. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics. 2011;6:828–37. - PMC - PubMed
    1. Marsit C, Christensen B. Blood-derived DNA methylation markers of cancer risk. Adv Exp Med Biol. 2013;754:233–52. - PubMed

Publication types

LinkOut - more resources